99 related articles for article (PubMed ID: 9808713)
21. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen.
Valentinis B; Porcu PL; Quinn K; Baserga R
Oncogene; 1994 Mar; 9(3):825-31. PubMed ID: 8108125
[TBL] [Abstract][Full Text] [Related]
22. PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I.
Escrivá F; González-Rodriguez A; Fernández-Millán E; Rondinone CM; Alvarez C; Valverde AM
J Cell Physiol; 2010 Oct; 225(1):214-22. PubMed ID: 20506299
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of Cdc2 and Aurora-A in Xenopus oocytes: a crucial role of phosphatase 2A.
Maton G; Lorca T; Girault JA; Ozon R; Jessus C
J Cell Sci; 2005 Jun; 118(Pt 11):2485-94. PubMed ID: 15923661
[TBL] [Abstract][Full Text] [Related]
24. Transforming potential of the insulin receptor substrate 1.
D'Ambrosio C; Keller SR; Morrione A; Lienhard GE; Baserga R; Surmacz E
Cell Growth Differ; 1995 May; 6(5):557-62. PubMed ID: 7647039
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1.
Pietrzkowski Z; Wernicke D; Porcu P; Jameson BA; Baserga R
Cancer Res; 1992 Dec; 52(23):6447-51. PubMed ID: 1423292
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid.
D'Ambrosio C; Valentinis B; Prisco M; Reiss K; Rubini M; Baserga R
Cancer Res; 1997 Aug; 57(15):3264-71. PubMed ID: 9242459
[TBL] [Abstract][Full Text] [Related]
27. S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase.
Spitkovsky D; Jansen-Dürr P; Karsenti E; Hoffman I
Oncogene; 1996 Jun; 12(12):2549-54. PubMed ID: 8700513
[TBL] [Abstract][Full Text] [Related]
28. The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity.
Vogt A; Pestell KE; Day BW; Lazo JS; Wipf P
Mol Cancer Ther; 2002 Sep; 1(11):885-92. PubMed ID: 12481409
[TBL] [Abstract][Full Text] [Related]
29. Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu.
Kiyokawa N; Karunagaran D; Lee EK; Xie Y; Yan DH; Hung MC
Oncogene; 1997 Nov; 15(22):2633-41. PubMed ID: 9400990
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen.
Oshima J; Steinmann KE; Campisi J; Schlegel R
Oncogene; 1993 Nov; 8(11):2987-93. PubMed ID: 8414501
[TBL] [Abstract][Full Text] [Related]
31. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases.
Wipf P; Aslan DC; Southwick EC; Lazo JS
Bioorg Med Chem Lett; 2001 Feb; 11(3):313-7. PubMed ID: 11212099
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle dependent regulation of cdc2 mRNA in mouse fibroblasts: requirement of protein synthesis and of continued mitogenic stimulation.
Buquet-Fagot C; Fagot D; Mester J
J Cell Physiol; 1993 Apr; 155(1):204-9. PubMed ID: 7682222
[TBL] [Abstract][Full Text] [Related]
33. Entry into mitosis without Cdc2 kinase activation.
Gowdy PM; Anderson HJ; Roberge M
J Cell Sci; 1998 Nov; 111 ( Pt 22)():3401-10. PubMed ID: 9788881
[TBL] [Abstract][Full Text] [Related]
34. Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array.
Ducruet AP; Rice RL; Tamura K; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
Bioorg Med Chem; 2000 Jun; 8(6):1451-66. PubMed ID: 10896122
[TBL] [Abstract][Full Text] [Related]
35. The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif.
Newberry EP; Boudreaux JM; Towler DA
Mol Endocrinol; 1996 Aug; 10(8):1029-40. PubMed ID: 8843419
[TBL] [Abstract][Full Text] [Related]
36. Drosophila development pulls the strings of the cell cycle.
Reed BH
Bioessays; 1995 Jun; 17(6):553-6. PubMed ID: 7575498
[TBL] [Abstract][Full Text] [Related]
37. Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells.
Patel R; Holt M; Philipova R; Moss S; Schulman H; Hidaka H; Whitaker M
J Biol Chem; 1999 Mar; 274(12):7958-68. PubMed ID: 10075693
[TBL] [Abstract][Full Text] [Related]
38. Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.
Krautheim A; Brechlin P; Becker K; Winkler M; Steinfelder HJ
Br J Pharmacol; 2000 Feb; 129(4):687-94. PubMed ID: 10683193
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2.
He J; Xu J; Xu XX; Hall RA
Oncogene; 2003 Jul; 22(29):4524-30. PubMed ID: 12881709
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle and growth factor-dependent phosphoprotein of 78kD differently regulated in normal and transformed mouse fibroblasts.
Yang HC; Pardee AB
J Cell Physiol; 1987 Nov; 133(2):377-82. PubMed ID: 3680394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
